SCHEMBL27314697

SCHEMBL27314697

CC(F)(F)Cc1cncc(Br)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C19 P33261 1/20 0.34
GRIN1 Q05586 1/20 0.34
GRIN2B Q13224 1/20 0.34
POLB P06746 1/20 0.33
HCAR2 Q8TDS4 1/20 0.33
KDM4E B2RXH2 1/20 0.33
SLC22A12 Q96S37 1/20 0.33
FDPS P14324 1/20 0.33
TACR1 P25103 1/20 0.32
SLC6A4 P31645 1/20 0.32
KCNH2 Q12809 1/20 0.32
PKM P14618 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16508616 0.88 HTT (0.38) MAPTHTTSMN1; SMN2CYP1A2CYP3A4
SCHEMBL8438131 0.84 CYP11B1 (0.38) MAPTHTTSMN1; SMN2CYP11B1CYP11B2
SCHEMBL27314699 0.77 POLB (0.41) CYP11B1CYP11B2POLBKDM4EFDPS
SCHEMBL30895742 0.73
SCHEMBL670394 0.73
SCHEMBL10223951 0.72 ESR1 (0.41) FDPS
SCHEMBL12065021 0.71 FDPS (0.39) MAPTHTTSMN1; SMN2KDM4EFDPS
SCHEMBL3664414 0.71 HTT (0.38) MAPTHTTSMN1; SMN2CYP1A2CYP3A4
SCHEMBL28790824 0.71 KDM4E (0.40) MAPTHTTSMN1; SMN2CYP1A2CYP3A4
SCHEMBL3659203 0.71 SMN1; SMN2 (0.38) MAPTHTTSMN1; SMN2CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024091542-A1 COMPOUNDS AND COMPOSITIONS AS GPR52 MODULATORS NEUROCRINE BIOSCIENCES, INC. (US) 2024-05-02 WO disclosed
WO-2024091542-A1 COMPOUNDS AND COMPOSITIONS AS GPR52 MODULATORS NEUROCRINE BIOSCIENCES, INC. (US) 2024-05-02 WO disclosed